Showing results (1-10 of 28,584) with videos related to

Sort By:
Pageof 2,859
JPMA. the Journal of the Pakistan Medical Association|November 17, 2025
Evaluating continuous nursing for elderly patients undergoing leukaemia chemotherapyBing Chen, Jing Wang, Xinmei Shen
Plos One|March 20, 2012
High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysisJing Wang, Qiguo Zhang, Rongfu Zhou, et al.
Acta Haematologica|July 10, 2010
Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trialsJing Wang, Jian Ouyang, Rongfu Zhou, et al.
Frontiers in Oncology|July 29, 2020
Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based StudyJing Wang, Min Zhou, Rongfu Zhou, et al.
Pharmacogenomics|December 16, 2015
A case of myeloid neoplasm with FIP1L1-PDGFRA rearrangement without marked peripheral blood eosinophiliaJing Wang, Qiguo Zhang, Hui Zeng, et al.
Oncotargets and Therapy|October 2, 2015
Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphomaJing Wang, Min Zhou, Jing-Yan Xu, et al.
Medical Oncology (Northwood, London, England)|April 8, 2010
Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysisJing Wang, Ping Zhan, Jian Ouyang, et al.
Leukemia Research|December 25, 2009
Unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: A meta-analysisJing Wang, Ping Zhan, Jian Ouyang, et al.
Leukemia Research|April 23, 2010
MTHFR C677T polymorphisms and childhood acute lymphoblastic leukemia: a meta-analysisJing Wang, Ping Zhan, Bing Chen, et al.
Oncotargets and Therapy|July 2, 2020
Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete RemissionMin Zhou, Jing Wang, Cui-Ping Li, et al.
Pageof 2,859